D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 45 Citations 5,874 114 World Ranking 3129 National Ranking 147

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Cancer

His primary areas of study are Immunology, Internal medicine, Myositis, Polymyositis and Dermatomyositis. Immunoglobulin G and Genetic enhancement is closely connected to Virology in his research, which is encompassed under the umbrella topic of Immunology. His Internal medicine research includes themes of Gastroenterology, Autoantibody and Weakness.

His work deals with themes such as Autoimmunity, Myocarditis and Myopathy, which intersect with Myositis. His Polymyositis research incorporates themes from Inflammation, Hepatitis B, Physical therapy and CD8. Olivier Benveniste combines subjects such as Interferon type I, Cancer research, Downregulation and upregulation and Myogenesis with his study of Dermatomyositis.

His most cited work include:

  • Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. (503 citations)
  • Long-term observational study of sporadic inclusion body myositis (190 citations)
  • Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. (169 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Immunology, Internal medicine, Myositis, Pathology and Dermatomyositis. His Immunology study is mostly concerned with Antibody, Autoantibody, Immune system, Inflammation and Cytokine. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery.

His studies deal with areas such as Arthritis, Myocarditis, Lung and Rheumatology as well as Myositis. Pathology is closely attributed to Muscle weakness in his study. His work is dedicated to discovering how Dermatomyositis, Polymyositis are connected with Pathogenesis and other disciplines.

He most often published in these fields:

  • Immunology (35.64%)
  • Internal medicine (29.76%)
  • Myositis (26.99%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (29.76%)
  • Myositis (26.99%)
  • Dermatomyositis (20.07%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Myositis, Dermatomyositis, Autoantibody and Immunology. In most of his Internal medicine studies, his work intersects topics such as Gastroenterology. Myositis is a subfield of Pathology that Olivier Benveniste tackles.

His Pathology research is multidisciplinary, incorporating elements of Muscular dystrophy and Immune system. His Autoantibody research integrates issues from Polymyositis, Weakness and Sub classification. Immunology and Mass cytometry are frequently intertwined in his study.

Between 2017 and 2021, his most popular works were:

  • Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer (113 citations)
  • 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. (106 citations)
  • Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. (101 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cancer

Internal medicine, Myositis, Autoantibody, Dermatomyositis and Pathology are his primary areas of study. His Internal medicine study incorporates themes from Gastroenterology and Rituximab. Olivier Benveniste is involved in the study of Myositis that focuses on Inclusion body myositis in particular.

His Autoantibody study improves the overall literature in Immunology. He has researched Dermatomyositis in several fields, including Interferon type I, Retrospective cohort study, Antisynthetase syndrome and Myogenin. His research in Pathology intersects with topics in Muscular dystrophy and Immune system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.

Sylvie Boutin;Virginie Monteilhet;Philippe Veron;Christian Leborgne.
Human Gene Therapy (2010)

775 Citations

Long-term observational study of sporadic inclusion body myositis

Olivier Benveniste;Marguerite Guiguet;Jane Freebody;Odile Dubourg.
Brain (2011)

249 Citations

Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.

Baptiste Hervier;Hervé Devilliers;Raluca Stanciu;Alain Meyer.
Autoimmunity Reviews (2012)

225 Citations

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

Yves Allenbach;Laurent Drouot;Aude Rigolet;Jean Luc Charuel.
Medicine (2014)

225 Citations

Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy.

Norma B. Romero;Serge Braun;Olivier Benveniste.
Human Gene Therapy (2004)

190 Citations

Correlation of anti–signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy

Olivier Benveniste;Laurent Drouot;Fabienne Jouen;Jean-Luc Charuel.
Arthritis & Rheumatism (2011)

172 Citations

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

Yves Allenbach;Jeremy Keraen;Anne-Marie Bouvier;Valérie Jooste.
Brain (2016)

161 Citations

Mechanisms Involved in the Low-Level Regeneration of CD4+ Cells in HIV-1—Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral Loads

Olivier Benveniste;Antoine Flahault;Florence Rollot;Carole Elbim.
The Journal of Infectious Diseases (2005)

151 Citations

Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

Benjamin Terrier;Guillaume Geri;Wahiba Chaara;Yves Allenbach.
Arthritis & Rheumatism (2012)

147 Citations

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

Mehdi Touat;Thierry Maisonobe;Samuel Knauss;Omar Ben Hadj Salem.
Neurology (2018)

145 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Olivier Benveniste

Ichizo Nishino

Ichizo Nishino

Tokyo Medical University

Publications: 58

Ingrid E. Lundberg

Ingrid E. Lundberg

Karolinska University Hospital

Publications: 40

Luc Mouthon

Luc Mouthon

Université Paris Cité

Publications: 32

Marinos C. Dalakas

Marinos C. Dalakas

Thomas Jefferson University

Publications: 28

Katherine A. High

Katherine A. High

Children's Hospital of Philadelphia

Publications: 28

Mavis Agbandje-McKenna

Mavis Agbandje-McKenna

University of Florida

Publications: 27

Neil McHugh

Neil McHugh

University of Bath

Publications: 26

Tsuneyo Mimori

Tsuneyo Mimori

Kyoto University

Publications: 22

Loïc Guillevin

Loïc Guillevin

Université Paris Cité

Publications: 22

Srini V. Kaveri

Srini V. Kaveri

Inserm : Institut national de la santé et de la recherche médicale

Publications: 21

Marvin J. Fritzler

Marvin J. Fritzler

University of Calgary

Publications: 21

Jean Sibilia

Jean Sibilia

University of Strasbourg

Publications: 20

Nils Erik Gilhus

Nils Erik Gilhus

Haukeland University Hospital

Publications: 20

Jerry R. Mendell

Jerry R. Mendell

The Ohio State University

Publications: 19

Jagadeesh Bayry

Jagadeesh Bayry

Inserm : Institut national de la santé et de la recherche médicale

Publications: 19

James M. Wilson

James M. Wilson

University of Pennsylvania

Publications: 18

Trending Scientists

Ramkishen S. Rajan

Ramkishen S. Rajan

National University of Singapore

Ryad Benosman

Ryad Benosman

University of Pittsburgh

Mauro Zigliotto

Mauro Zigliotto

University of Padua

Alain J. Martin

Alain J. Martin

California Institute of Technology

Tadeusz Lis

Tadeusz Lis

University of Wrocław

Qiyuan He

Qiyuan He

City University of Hong Kong

André Pineau

André Pineau

Mines ParisTech

Paul S. Mead

Paul S. Mead

Centers for Disease Control and Prevention

Shi-Yong Sun

Shi-Yong Sun

Emory University

Martha M. Moore

Martha M. Moore

National Center for Toxicological Research

Frank J. M. van Kuppeveld

Frank J. M. van Kuppeveld

Utrecht University

Ian Wright

Ian Wright

The Open University

Dong L. Wu

Dong L. Wu

California Institute of Technology

Sara J. Czaja

Sara J. Czaja

Cornell University

William L. Young

William L. Young

University of California, San Francisco

David M. Hansell

David M. Hansell

National Institutes of Health

Something went wrong. Please try again later.